Trial intelligence / Profile preview

Varenicline for smokeless tobacco cessation

NCT00717093Phase 4Completed

Sponsor
Pfizer
Start
Aug 2008
Primary completion
Apr 2009
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of varenicline in Tobacco Use Disorder (TUD), sponsored by Pfizer. Started Aug 2008; status: completed.

02

Drugs

varenicline
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00717093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00717093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call